BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32783525)

  • 1. FOXP3, CD208, and CD206 Expression in Canine Cutaneous Histiocytoma.
    Belluco S; Sammarco A; Sapin P; Lurier T; Marchal T
    Vet Pathol; 2020 Sep; 57(5):599-607. PubMed ID: 32783525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses CD1 and specific beta 2-integrin molecules.
    Moore PF; Schrenzel MD; Affolter VK; Olivry T; Naydan D
    Am J Pathol; 1996 May; 148(5):1699-708. PubMed ID: 8623937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin expression in canine cutaneous histiocytomas.
    Baines SJ; McInnes EF; McConnell I
    Vet Rec; 2008 Apr; 162(16):509-13. PubMed ID: 18424847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regression of a canine Langerhans cell tumour is associated with increased expression of IL-2, TNF-alpha, IFN-gamma and iNOS mRNA.
    Kaim U; Moritz A; Failing K; Baumgärtner W
    Immunology; 2006 Aug; 118(4):472-82. PubMed ID: 16764690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic and ultrastructural evidence of the langerhans cell origin of the canine cutaneous histiocytoma.
    Marchal T; Dezutter-Dambuyant C; Fournel C; Magnol JP; Schmitt D
    Acta Anat (Basel); 1995; 153(3):189-202. PubMed ID: 8984828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomorphometry of canine cutaneous histiocytoma.
    Paździor-Czapula K; Otrocka-Domagała I; Rotkiewicz T; Gesek M
    Pol J Vet Sci; 2014; 17(3):413-20. PubMed ID: 25286647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCH cells are potent stimulators in the allogeneic mixed leucocyte reaction.
    Baines SJ; Blacklaws BA; McInnes E; McConnell IM
    Vet Immunol Immunopathol; 2007 Oct; 119(3-4):316-21. PubMed ID: 17675250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of major histocompatibility complex class II antigen in neoplastic cells of canine cutaneous histiocytoma.
    Kipar A; Baumgärtner W; Kremmer E; Frese K; Weiss E
    Vet Immunol Immunopathol; 1998 Mar; 62(1):1-13. PubMed ID: 9618864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin expression in canine cutaneous histiocytoma.
    Pires I; Alves A; Rodrigues P; Queiroga FL; Lopes CS
    Vet Rec; 2008 Jul; 163(2):59-60; author reply 60. PubMed ID: 18622005
    [No Abstract]   [Full Text] [Related]  

  • 10. FoxP3 and IDO in Canine Melanocytic Tumors.
    Porcellato I; Brachelente C; De Paolis L; Menchetti L; Silvestri S; Sforna M; Vichi G; Iussich S; Mechelli L
    Vet Pathol; 2019 Mar; 56(2):189-199. PubMed ID: 30381008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronmicroscopic study of canine cutaneous histiocytoma: a benign Langerhans cell tumor.
    Marchal T; Dezutter-Dambuyant C; Fournel C; Magnol JP; Schmitt D
    Adv Exp Med Biol; 1995; 378():549-51. PubMed ID: 8526139
    [No Abstract]   [Full Text] [Related]  

  • 12. Patterns of lymphoid infiltrate in the canine cutaneous histiocytoma.
    Cockerell GL; Slauson DO
    J Comp Pathol; 1979 Apr; 89(2):193-203. PubMed ID: 222817
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple, resolving, cutaneous histiocytoma in a dog.
    Bender WM; Muller GH
    J Am Vet Med Assoc; 1989 Feb; 194(4):535-7. PubMed ID: 2537810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors.
    Fernandez NJ; West KH; Jackson ML; Kidney BA
    Vet Pathol; 2005 Jul; 42(4):437-45. PubMed ID: 16006603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of canine cutaneous histiocytoma: reduced proliferation or increased apoptosis?
    Pires I; Alves A; Queiroga FL; Silva F; Lopes C
    Anticancer Res; 2013 Apr; 33(4):1397-400. PubMed ID: 23564778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
    Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
    Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and immunoelectron study of major histocompatibility complex class-II antigen in canine cutaneous histiocytoma: its relation to tumor regression.
    Pires I; Rodrigues P; Alves A; Queiroga FL; Silva F; Lopes C
    In Vivo; 2013; 27(2):257-62. PubMed ID: 23422487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of CD3, FoxP3, and granzyme B immunostaining in canine renal cell carcinoma.
    Cournoyer A; Amerman H; Assenmacher CA; Durham A; Perry JA; Gedney A; Keuler N; Atherton MJ; Lenz JA
    Vet Immunol Immunopathol; 2024 May; 271():110741. PubMed ID: 38520894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous histiocytoma in a heifer.
    Sutton RH; McLennan MW
    J Comp Pathol; 1987 Jul; 97(4):463-8. PubMed ID: 2822780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Bartonella spp. in Canine Cutaneous Histiocytoma.
    Pultorak EL; Linder K; Maggi RG; Balakrishnan N; Breitschwerdt EB
    J Comp Pathol; 2015 Jul; 153(1):14-21. PubMed ID: 25980841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.